<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6066501</article-id><article-id pub-id-type="doi">10.3389/fimmu.2018.01723</article-id><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>Regulation of Phagocytosis in Macrophages by Membrane Ethanolamine Plasmalogens</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Rubio</surname><given-names>Julio M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/548033"/></contrib><contrib contrib-type="author"><name><surname>Astudillo</surname><given-names>Alma M.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/477344"/></contrib><contrib contrib-type="author"><name><surname>Casas</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/543134"/></contrib><contrib contrib-type="author"><name><surname>Balboa</surname><given-names>Mar&#x000ed;a A.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/479837"/></contrib><contrib contrib-type="author"><name><surname>Balsinde</surname><given-names>Jes&#x000fa;s</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="fn001">*</xref><uri xlink:type="simple" xlink:href="https://frontiersin.org/people/u/465839"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Instituto de Biolog&#x000ed;a y Gen&#x000e9;tica Molecular, Consejo Superior de Investigaciones Cient&#x000ed;ficas (CSIC), Universidad de Valladolid</institution>, <addr-line>Valladolid</addr-line>, <country>Spain</country></aff><aff id="aff2"><sup>2</sup><institution>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Diabetes y Enfermedades Metab&#x000f3;licas Asociadas (CIBERDEM)</institution>, <addr-line>Madrid</addr-line>, <country>Spain</country></aff><aff id="aff3"><sup>3</sup><institution>Departamento de Bioqu&#x000ed;mica y Fisiolog&#x000ed;a, Universidad de Valladolid</institution>, <addr-line>Valladolid</addr-line>, <country>Spain</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Kottarappat N. Dileepan, Kansas University of Medical Center Research Institute, United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Krzysztof Guzik, Jagiellonian University, Poland; Arnaud Millet, INSERM U1209 Institut pour l&#x02019;Avanc&#x000e9;e des Biosciences (IAB), France</p></fn><corresp id="fn001">*Correspondence: Jes&#x000fa;s Balsinde, <email>jbalsinde@ibgm.uva.es</email></corresp><fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>24</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>1723</elocation-id><history><date date-type="received"><day>23</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>12</day><month>7</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Rubio, Astudillo, Casas, Balboa and Balsinde.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Rubio, Astudillo, Casas, Balboa and Balsinde</copyright-holder><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Macrophages, as professional phagocytes of the immune system, possess the ability to detect and clear invading pathogens and apoptotic cells through phagocytosis. Phagocytosis involves membrane reorganization and remodeling events on the cell surface, which play an essential role in innate immunity and tissue homeostasis and the control of inflammation. In this work, we report that cells deficient in membrane ethanolamine plasmalogen demonstrate a reduced capacity to phagocytize opsonized zymosan particles. Amelioration of plasmalogen deficiency in these cells by incubation with lysoplasmalogen results in a significant augmentation of the phagocytic capacity of the cells. In parallel with these increases, restoration of plasmalogen levels in the cells also increases the number and size of lipid rafts in the membrane, reduces membrane fluidity down to levels found in cells containing normal plasmalogen levels, and improves receptor-mediated signaling. Collectively, these results suggest that membrane plasmalogen level determines characteristics of the plasma membrane such as fluidity and the formation of microdomains that are necessary for efficient signal transduction leading to optimal phagocytosis by macrophages.</p></abstract><kwd-group><kwd>ethanolamine plasmalogen</kwd><kwd>phagocytosis</kwd><kwd>arachidonic acid</kwd><kwd>inflammation</kwd><kwd>monocytes/macrophages</kwd></kwd-group><funding-group><award-group><funding-source id="cn01">Ministerio de Econom&#x000ed;a y Competitividad<named-content content-type="fundref-id">10.13039/501100003329</named-content></funding-source><award-id rid="cn01">SAF2016-80883-R, SAF2015-73000-EXP</award-id></award-group><award-group><funding-source id="cn02">Consejer&#x000ed;a de Educaci&#x000f3;n, Junta de Castilla y Le&#x000f3;n<named-content content-type="fundref-id">10.13039/501100008431</named-content></funding-source><award-id rid="cn02">CSI073U16</award-id></award-group></funding-group><counts><fig-count count="8"/><table-count count="0"/><equation-count count="0"/><ref-count count="83"/><page-count count="14"/><word-count count="7988"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Macrophages play key functions in innate and inflammation by clearing pathogens, damaged cells, and debris <italic>via</italic> highly regulated phagocytosis processes, which aim at efficiently restoring tissue homeostasis (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). To carry out this function, macrophages are endowed with a variety of cell surface receptors, collectively called opsonin-independent receptors, which include the C-type lectins such as dectin-1 and the mannose receptor; scavenger receptors such as SR-A-I, SR-A-II, MARCO, and CD36; and toll-like receptors such as TLR-2 and TLR-6 (<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B6" ref-type="bibr">6</xref>). To improve recognition of phagocytosable material, pathogens, damaged cells, or debris can be opsonized by immunoglobulins and complement and be recognized by opsonin-dependent receptors such as the Fc receptors Fc&#x003b3;RI, Fc&#x003b3;RII, and Fc&#x003b3;RIII, and the complement receptors CR1, CR3, and CR4 (<xref rid="B6" ref-type="bibr">6</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>). Engagement of phagocytic receptors, both non-opsonic and opsonic, triggers the synthesis and release of an ample variety of mediators such as cytokines, chemokines, and arachidonic acid-derived eicosanoids that regulate the inflammatory response (<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>).</p><p>A number of phagocytic receptors have been localized or are recruited upon activation to membrane microdomains called lipid rafts, including both non-opsonic (TLR-2, TLR-6, and dectin-1) and opsonic (Fc&#x003b3;R and CR3) (<xref rid="B9" ref-type="bibr">9</xref>&#x02013;<xref rid="B16" ref-type="bibr">16</xref>). Lipid rafts are highly dynamic and tightly ordered membrane microdomains enriched in cholesterol, glycosphingolipids, and glycosylphosphatidylinositol-linked proteins. Lipid rafts are involved in numerous cell functions, which include cell signaling, membrane sorting and trafficking, migration, cell adhesion (<xref rid="B17" ref-type="bibr">17</xref>&#x02013;<xref rid="B19" ref-type="bibr">19</xref>), as well as phagocytic and pathogen entry processes (<xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B21" ref-type="bibr">21</xref>).</p><p>Plasmalogens are also ubiquitously found within lipid rafts (<xref rid="B22" ref-type="bibr">22</xref>). These are glycerophospholipids with a vinyl ether bond in the <italic>sn-1</italic> position of the glycerol backbone. Thus the <italic>sn-1</italic> position in plasmalogens is occupied by a fatty alcohol, not a fatty acid as it is common for most membrane glycerophospholipids. Ethanolamine is the most frequent headgroup present in mammalian plasmalogens (<xref rid="B23" ref-type="bibr">23</xref>). Macrophages are rich sources of ethanolamine plasmalogens, which localize primarily in the inner leaflet of the plasma membrane and present an unusual enrichment in polyunsaturated fatty acids, most notably arachidonic acid, in the <italic>sn-2</italic> position (<xref rid="B23" ref-type="bibr">23</xref>&#x02013;<xref rid="B25" ref-type="bibr">25</xref>). Given the importance of macrophages as major sources of arachidonate-derived eicosanoids as mediators of inflammation, the key role of ethanolamine plasmalogens in arachidonic acid mobilization reactions has been long recognized (<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). Because of the vinyl ether bond of ethanolamine plasmalogens, these phospholipids have also been found to play roles as endogenous antioxidants and in the regulation of plasma membrane biophysical properties such as fluidity, fusion tendency, and thickness (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>).</p><p>Previous work from our laboratory has investigated the mechanisms regulating phospholipid turnover <italic>via</italic> deacylation/reacylation reactions during phagocytosis, as well as the phospholipase A<sub>2</sub> forms involved (<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>). Results from these studies have identified discrete lipid metabolites whose synthesis appears to be associated with specific stimulation conditions and thus, may allow the identification of specific attributes of the immune response as regards the lipid pathways and metabolites involved (<xref rid="B30" ref-type="bibr">30</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>). In this study, we have applied similar mass-spectrometry-based lipidomic and confocal microscopy approaches to investigate the role of plasmalogens during phagocytosis. Taking advantage as well of the use of plasmalogen-deficient cells (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>), we show that reduction in plasmalogen levels leads to altered phagocytosis of opsonized zymosan (OpZ) particles by macrophages which can be attributed to changes in the plasma membrane fluidity and the formation and functioning of the lipid rafts. We further show that these alterations can be significantly reversed when cellular plasmalogen levels are increased by incubating the cells with lysoplasmalogens, which incorporate into the cells and restore the cellular plasmalogen pool.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><sec id="S2-1"><title>Reagents</title><p>Dulbecco&#x02019;s modified Eagle&#x02019;s medium (DMEM) was from Lonza (Basel, Switzerland). Zymosan A, labeled with Alexa Fluor 594, and cholera toxin B subunit (recombinant) labeled with Alexa Fluor 647 were from Molecular Probes (Carlsbad, CA, USA). Chloroform and methanol, 2-propanol, <italic>n</italic>-hexane and ammonium acetate (HPLC grade) were from Fisher Scientific (Hampton, NH, USA). Lipids and standards for mass spectrometry were purchased from Avanti Polar Lipids (Alabaster, AL, USA), Cayman (Ann Arbor, MI, USA), or Larodan Fine Chemicals (Malmoe, Sweden). The antibodies against phosphorylated and non-phosphorylated extracellular signal-regulated kinases p44/p42 were from Cell Signaling (Amherst, MA, USA). All other reagents were from Sigma-Aldrich.</p></sec><sec id="S2-2"><title>Cell Culture Conditions</title><p>RAW264.7 macrophage-like cells and the ether phospholipid-deficient RAW.108 cells (a generous gift from Dr. R.A. Zoeller, Boston University) (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>) were grown in DMEM supplemented with 10% (v/v) fetal bovine serum, 100&#x02009;U/ml penicillin, 100&#x02009;&#x000b5;g/ml streptomycin, and 2&#x02009;mM <sc>l</sc>-glutamine at 37&#x000b0;C in a humidified atmosphere of 5% CO<sub>2</sub> at 37&#x000b0;C, exactly as described (<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B37" ref-type="bibr">37</xref>). For experiments, the cells were treated in DMEM without serum for 1&#x02009;h before addition of the various stimulants for the indicated concentrations and periods of time. Zymosan particles were prepared as described elsewhere (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Only zymosan preparations that were shown not to contain endogenous phospholipase A<sub>2</sub> activity, as measured by enzyme assay (<xref rid="B46" ref-type="bibr">46</xref>&#x02013;<xref rid="B50" ref-type="bibr">50</xref>), were used in this study. Cell protein was measured according to Bradford (<xref rid="B51" ref-type="bibr">51</xref>), using the BioRad kit.</p></sec><sec id="S2-3"><title>Phagocytosis Assay</title><p>Opsonized zymosan, labeled with the fluorophore Alexa Fluor 594, or opsonized latex beads (3&#x02009;&#x000b5;m particle size) were used as a stimulus. The zymosan particles and latex beads were opsonized by incubation with murine serum for 20&#x02009;min at 37&#x000b0;C, at a ratio of 1&#x02009;ml serum per 10&#x02009;mg particles (<xref rid="B38" ref-type="bibr">38</xref>). The cells were seeded over glass coverslips, allowed to adhere, washed with DMEM, and resuspended in this medium. OpZ or opsonized latex beads were added and, after a 30-min incubation at 37&#x000b0;C, coverslips were washed with PBS and transferred to plates at 37&#x000b0;C, and phagocytosis was allowed to proceed for 30&#x02009;min. Reactions were stopped by fixation with 4% paraformaldehyde in PBS containing 3% sucrose for 15&#x02009;min. Afterward, paraformaldehyde was removed by washing the cells three times with PBS. DAPI staining was carried out by treating cells with this dye at a concentration of 1&#x02009;&#x000b5;g/ml in PBS for 10&#x02009;min. Coverslips were mounted on microscopy slides with 10&#x02009;&#x000b5;l a polyvinyl alcohol solution until analysis by fluorescence microscopy. A Leica TCS SP5 X confocal microscope with white laser (470&#x02013;670&#x02009;nm) (Leica Microsystem, Wetzlar, Germany) was used for these studies. Images were analyzed with LAS AF v. 2.6.3 (Leica) and ImageJ (National Institutes of Health, USA; <uri xlink:type="simple" xlink:href="http://rsb.info.nih.gov/ij/">http://rsb.info.nih.gov/ij/</uri>). The phagocytic index was calculated by dividing the number of phagosomes by the total number of cells in a field, which was multiplied by the percentage of phagocytosing cells, as described elsewhere (<xref rid="B52" ref-type="bibr">52</xref>).</p></sec><sec id="S2-4"><title>Flow Cytometry Analyses</title><p>The cells were incubated with latex beads (yellow-green fluorescent FluoSpheres<sup>&#x000ae;</sup> Microspheres of 1&#x02009;&#x000b5;m size, 488&#x02009;nm spectral line; 5&#x02013;7 particles/cell) (Molecular Probes&#x02122;) or OpZ (labeled with Alexa Fluor 488; 5&#x02013;7 particles/cell) for 30&#x02009;min at 37&#x000b0;C. Afterward the cells were washed thrice with PBS to remove the particles, and fresh medium was added to allow phagocytosis to complete. Then the cells were washed again with PBS and harvested with TrypLE&#x02122; Express Enzyme (Gibco, Thermo Fisher). Cell fluorescence was quantified by flow cytometry using a Beckman Coulter Gallios cytofluorometer. Data were analyzed with the Kaluza software, version 1.5a.</p><p>For the analysis of apoptotic cell phagocytosis by macrophages, apoptotic Jurkat T cells were used. Apoptotic cell death was induced in these cells by treating them with 500&#x02009;&#x000b5;M H<sub>2</sub>O<sub>2</sub> for 20&#x02009;h (<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>). Afterward, the Jurkat cells were stained with 50&#x02009;&#x000b5;M propidium iodide for 20&#x02009;min. After washing the cells twice with PBS, target cells were added to the RAW 264.7 or RAW.108 macrophage monolayers in a final volume of 1.5&#x02009;ml of DMEM. The macrophages had previously been stained with CellTracker&#x02122; Deep Red Dye (ThermoFisher). The plates were centrifuged at 300&#x02009;<italic>g</italic> for 3&#x02009;min so as to bring the target cells into direct contact with the macrophages. The ratio of target cells to macrophages was 3:1. The phagocytosis reaction was allowed to proceed for 2&#x02009;h in a humidified CO<sub>2</sub> incubator at 37&#x000b0;C, after which the macrophages were harvested with TrypLE&#x02122; Express Enzyme. The macrophages were then washed twice with PBS and analyzed by flow cytometry using a Beckman Coulter Gallios cytofluorometer. Deep red fluorescence from CellTracker&#x02122; Deep Red Dye was analyzed in FL6, while red fluorescence from propidium iodide was analyzed in FL3. To quantify phagocytosis, red fluorescence was analyzed only in the cell populations exhibiting significant deep red fluorescence (i.e., the macrophages). Macrophages are double positive for red and deep red fluorescence only if they ingested the propidium iodide-labeled Jurkat cells.</p></sec><sec id="S2-5"><title>Analysis of Lipid Rafts</title><p>When needed, RAW cells were stained for lipid raft visualization with Alexa Fluor 647-labeled cholera toxin B subunit (CT-B) following the manufacturer&#x02019;s experimental protocol (Molecular Probes, Carlsbad, CA, USA). Cells were washed twice with cold PBS and fixed in 4% paraformaldehyde in PBS containing 3% sucrose for 15&#x02009;min. After several washes, the glasses were placed and mounted onto slide for microscopy.</p><p>For all microscopy measurements, the staining pattern of cells from three separate and independent experiments was considered (20&#x02013;35 cells total per treatment). The size of lipid rafts was determined by analyzing particles that were &#x02265;0.1&#x02009;&#x003bc;m<sup>2</sup> with ImageJ (<xref rid="B55" ref-type="bibr">55</xref>). This threshold was selected because an area smaller than 0.1&#x02009;&#x000b5;m<sup>2</sup> results in domains that could not be accurately measured. The lipid raft number was determined for each cell and averaged for all cells for a given treatment. The data were then averaged for all cells per treatment group from all the independent measurements.</p></sec><sec id="S2-6"><title>Fluorescence Recovery After Photobleaching (FRAP)</title><p>The cells were maintained in imaging medium (HBSS pH 7.4, 25&#x02009;mM HEPES, 1.3&#x02009;mM CaCl<sub>2</sub>, and 1.3&#x02009;mM MgCl<sub>2</sub>) at 37&#x000b0;C with 5% CO<sub>2</sub> in a cage incubator attached to the microscope. Images were captured using an oil immersion, 63&#x000d7;, 1.4 NA, HCX PL APO CS objective in a confocal microscope at 37&#x000b0;C (TCS SP5X; Leica). Briefly, a rectangular region of interest of 6&#x02009;&#x000b5;m<sup>2</sup> (3&#x02009;&#x000d7;&#x02009;2&#x02009;&#x000b5;m) was defined within the plasma membrane for effective bleaching, 650&#x02009;nm white laser was set at 100% power for a pulse of 0.834&#x02009;s. 10 Prebleach images and 100 postbleach images were acquired at 20% of the maximum laser power, with a 256&#x02009;&#x000d7;&#x02009;256 pixels resolution, 8 bits and full scanning speed at 1,000&#x02009;Hz every 0.278&#x02009;s. Pinhole size was optimized to 238.8&#x02009;&#x000b5;m aperture. A minimum of 40 cells per condition was analyzed with ImageJ software. FRAP measurements were full-scale normalized according to the method described by Giakoumakis et al. (<xref rid="B56" ref-type="bibr">56</xref>). The resulting data were fit to a single exponential curve model, and the mobile fraction of plasma membrane was calculated (<xref rid="B56" ref-type="bibr">56</xref>&#x02013;<xref rid="B58" ref-type="bibr">58</xref>).</p></sec><sec id="S2-7"><title>Lipid Analysis by Mass Spectrometry</title><p>Analysis of phospholipids by liquid chromatography coupled to mass spectrometry was carried out as described elsewhere (<xref rid="B34" ref-type="bibr">34</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>), using an Agilent 1260 Infinity high-performance liquid chromatograph equipped with an Agilent G1311C quaternary pump and an Agilent G1329B Autosampler, coupled to an API2000 triple quadrupole mass spectrometer (Applied Biosystems). Phospholipid molecular species were identified by comparison with previously published data (<xref rid="B34" ref-type="bibr">34</xref>&#x02013;<xref rid="B41" ref-type="bibr">41</xref>). Lipid analysis by gas chromatography coupled to mass spectrometry was carried out exactly as described elsewhere (<xref rid="B59" ref-type="bibr">59</xref>&#x02013;<xref rid="B63" ref-type="bibr">63</xref>), using an Agilent 7890A gas chromatograph coupled to an Agilent 5975C mass selective detector operated in electron impact mode, equipped with an Agilent 7693 Autosampler and an Agilent DB23 column (60&#x02009;m length&#x02009;&#x000d7;&#x02009;0.25&#x02009;mm internal diameter&#x02009;&#x000d7;&#x02009;0.15&#x02009;&#x000b5;m film thickness).</p></sec><sec id="S2-8"><title>Immunoblot Analysis</title><p>This was carried out exactly as described elsewhere (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). The immunoblots were visualized using enhanced luminescence. Densitometry was performed on scanned images using Quantity One<sup>&#x000ae;</sup> software (Bio-Rad), and values were normalized for the corresponding controls of each experiment.</p></sec><sec id="S2-9"><title>Statistical Analysis</title><p>All experiments were carried out at least three times with incubations in duplicate or triplicate, and the data are expressed as mean&#x02009;&#x000b1;&#x02009;SE. Statistical analysis was carried out by Student&#x02019;s <italic>t</italic>-test, with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 taken as statistically significant.</p></sec></sec><sec id="S3"><title>Results</title><p>In previous work from our laboratory, we demonstrated that phospholipase A<sub>2</sub>-mediated hydrolysis of ethanolamine-containing phospholipids at the membrane is a key event to support phagocytosis of yeast-derived zymosan and live bacteria by human macrophages (<xref rid="B40" ref-type="bibr">40</xref>). To explore further the involvement of ethanolamine-containing membrane phospholipids in phagocytosis, in this work we took advantage of the use of an ethanolamine plasmalogen-defective variant of the RAW 264.7 cell line, called RAW.108 (<xref rid="B42" ref-type="bibr">42</xref>, <xref rid="B43" ref-type="bibr">43</xref>). RAW 264.7 macrophage-like cells are extensively utilized as a prototypical model for studies on macrophage metabolism and signaling (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). These cells phagocytize non-OpZ particles rather poorly, which is believed to be due to a very low expression level of dectin-1 in these cells (<xref rid="B3" ref-type="bibr">3</xref>). However, opsonization of the zymosan with serum, which allows recognition of the particles by complement receptors-1, -3, and -4, and Fc&#x003b3; receptors (<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B8" ref-type="bibr">8</xref>), results in the cells phagocytizing the stimulus to a much greater extent (Figure <xref ref-type="fig" rid="F1">1</xref>). Interestingly, phagocytosis of OpZ particles was significantly impaired in the ethanolamine plasmalogen-deficient RAW.108 cells (Figure <xref ref-type="fig" rid="F1">1</xref>). Comparative lipidomic analyses of wild-type cells versus RAW.108 cells by mass spectrometry confirmed the practically complete absence of plasmalogens in the latter (Figure <xref ref-type="fig" rid="F2">2</xref>). Importantly, however, the total amount of cellular arachidonate-containing ethanolamine phospholipid was preserved, because of a compensatory elevation of non-plasmalogen ethanolamine phospholipids (i.e., the diacyl species) (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Phagocytosis of zymosan particles in RAW 264.7 and plasmalogen-deficient RAW.108 cells. The cells were exposed to fluorescent non-opsonized (Zym) or opsonized zymosan (OpZ) particles for 30&#x02009;min, as indicated (10 particles per cell, equivalent to approximately 0.2&#x02009;mg per million cells), and analyzed for phagocytosis of fluorescent zymosan particles by confocal microscopy (red color, middle columns). DAPI (1&#x02009;&#x000b5;g/ml) was used to mark the nuclei (blue, left columns). Nomarski and merge images are also shown (right columns). The average of three independent experiments with 20 determinations each is shown (mean&#x02009;&#x000b1;&#x02009;SEM) (bottom panel). Original magnification, &#x000d7;20. **Significantly different (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) from RAW 264.7 cells exposed to OpZ.</p></caption><graphic xlink:href="fimmu-09-01723-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Ethanolamine plasmalogen content of RAW 264.7 and RAW.108 cells. Analyses were carried out by liquid chromatography coupled to mass spectrometry. The fatty acid distribution within plasmalogen species containing hexadecyl (P-16:0) <bold>(A)</bold>, octadecenyl (P-18:1) <bold>(B)</bold>, or octadecyl (P-18:0) <bold>(C)</bold> moieties at <italic>sn-1</italic> position is shown. Fatty acids (abscissa) are abbreviated as carbon number:double bonds. In <bold>(D)</bold>, the distribution of arachidonic acid (20:4) moieties in ethanolamine phospholipids (including plasmalogen and diacyl species) in RAW 264.7 cells versus RAW.108 cells is shown. Results are given as mean&#x02009;&#x000b1;&#x02009;SEM of three independent experiments carried out in duplicate.</p></caption><graphic xlink:href="fimmu-09-01723-g002"/></fig><p>To determine whether the phagocytic response of RAW.108 cells could be restored by exogenously increasing cellular plasmalogen levels, we preincubated the cells with 10&#x02009;&#x000b5;M lysoplasmenylethanolamine (1-<italic>O</italic>-1&#x02032;-octadecyl-2-lyso-<italic>sn</italic>-glycero-3-phosphoethanolamine, lysoPlsEtn), so that the cells incorporated and reacylated it, thus replenishing their cellular plasmalogen pool. Under our assay conditions in cell culture media, the critical micellar concentration for the lysophospholipids used in this study was estimated to be between 15 and 20&#x02009;&#x000b5;M. This result, which is similar to data by others (<xref rid="B67" ref-type="bibr">67</xref>), indicates that at the concentrations used the lysophospholipids are primarily in monomeric form. This avoids undesired nonspecific effects stemming from the formation of aggregates of varying sizes and shapes that could interact with the cells (<xref rid="B40" ref-type="bibr">40</xref>).</p><p>Figure <xref ref-type="fig" rid="F3">3</xref> shows that treatment with lysoPlsEtn significantly elevated the amount of plasmalogen in the RAW.108 cells, especially that containing arachidonic acid (20:4), which increased to levels close to 60&#x02013;70% of those of normal RAW 264.7 cells. Interestingly, addition of lysoPlsEtn to normal RAW 264.7 cells increased only slightly the amount of cellular ethanolamine plasmalogen in these cells, suggesting that the capacity of this pool to expand is limited and, in turn, that normal RAW 264.7 cells already contain the requisite plasmalogen that is necessary for cell function (Figure <xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Incubation of RAW.108 cells with lysoPlsEtn increases plasmalogen content. RAW 264.7 cells (top panel) or RAW.108 cells (bottom panel) were incubated without (dark blue bars) or with 10&#x02009;&#x000b5;M lysoPlsEtn (cyan bars) for 40&#x02009;min. Afterward, cellular plasmalogen content was determined by liquid chromatography coupled to mass spectrometry. Results are given as mean&#x02009;&#x000b1;&#x02009;SEM of three independent experiments carried out in duplicate.</p></caption><graphic xlink:href="fimmu-09-01723-g003"/></fig><p>Assays utilizing cells incubated with lysoPlsEtn showed that this simple treatment was enough to increase the capacity of RAW.108 cells to phagocytize the OpZ (Figure <xref ref-type="fig" rid="F4">4</xref>). The phagocytic capacity of normal RAW 264.7 cells was also augmented by lysoPlsEtn treatment, albeit the increase was lower, in relative terms, than that found for RAW.108 cells (Figure <xref ref-type="fig" rid="F4">4</xref>). Importantly, control experiments utilizing lysophosphatidylethanolamine (1-oleoyl-2-lyso-<italic>sn</italic>-glycero-3-phosphoethanolamine, lysoPtdEtn) instead of lysoPlsEtn, showed no effect on zymosan phagocytosis in either RAW 264.7 or RAW.108 cells (Figure <xref ref-type="fig" rid="F4">4</xref>), indicating specificity for the plasmalogen subclass; thus the presence of an alkenyl substituent at the <italic>sn-1</italic> position of the glycerol moiety appears to be necessary for the biological effect to manifest.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Effect of lysoPlsEtn on the phagocytosis of opsonized zymosan by RAW 264.7 and plasmalogen-deficient RAW.108 cells. The cells were either untreated (brown bars) or treated with 10&#x02009;&#x000b5;M lysoPlsEtn (orange bars) or 10&#x02009;&#x000b5;M lysoPtdEtn (yellow bars) for 10&#x02009;min. Afterward, fluorescent zymosan particles (10 particles per cell) were added for 30&#x02009;min, and phagocytosis was analyzed by confocal microscopy (red color, middle columns). DAPI (1&#x02009;&#x000b5;g/ml) was used to mark the nuclei (blue; left columns). Nomarski images are also shown (right columns). The average of three independent experiments with 20 determinations each is shown in the bottom panel (mean&#x02009;&#x000b1;&#x02009;SEM). Phagocytic indexes in the bottom panel are given as percent values with respect to controls without added lysophospholipids to allow for direct comparison between the responses of RAW 264.7 cells versus RAW.108 cells. Actual values were 112&#x02009;&#x000b1;&#x02009;4 and 49&#x02009;&#x000b1;&#x02009;2 for RAW 264.7 cells and RAW.108 cells, respectively. Original magnification, &#x000d7;20. **Significantly different (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) from untreated cells.</p></caption><graphic xlink:href="fimmu-09-01723-g004"/></fig><p>To extend these results to other forms of phagocytosis, we assayed the effect of lysoPlsEtn on other phagocytic targets such as fluorescent latex beads (non-opsonized) and apoptotic cells. As shown in Figure <xref ref-type="fig" rid="F5">5</xref>, incubation of macrophages with lysoPlsEtn did significantly increase the capacity of RAW.108 cells to phagocytize both unopsonized latex beads and apoptotic cells; however, the extent of the effect was smaller than that found when OpZ was used as a target. We note that phagocytosis of apoptotic cells was not verified by confocal microscopy, so we cannot rule out that an undetermined amount of fluorescence arising from ingested material is due to phagocytized apoptotic cell debris. Collectively, these results suggest that while ethanolamine plasmalogens play a general role in regulating phagocytosis, their effect is particularly marked for opsonic phagocytosis.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p>Effect of lysoPlsEtn on the phagocytosis of different targets by RAW 264.7 and plasmalogen-deficient RAW.108 cells. The cells were either untreated or treated with 10&#x02009;&#x000b5;M lysoPlsEtn or 10&#x02009;&#x000b5;M lysoPtdEtn for 10&#x02009;min as indicated. Afterward, unopsonized latex beads (5&#x02013;7 particles/cell, 30-min incubation) or apoptotic Jurkat cells (ratio 3:1, 2-h incubation) were added, and phagocytosis was analyzed by flow cytometry. Measurements run in parallel using opsonized zymosan particles (OpZ, 5&#x02013;7 particles/cell) are also shown for direct comparison. *Significantly different (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) from untreated cells; **significantly different (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) from untreated cells.</p></caption><graphic xlink:href="fimmu-09-01723-g005"/></fig><p>Ethanolamine plasmalogens are frequent constituents of membrane lipid rafts (<xref rid="B22" ref-type="bibr">22</xref>). Thus, in the next series of experiments, confocal microscopy analyses of lipid rafts were carried out to determine the influence of plasmalogen content on these structures, as well as their relation with phagocytosis. Lipid rafts were visualized with Alexa Fluor 647-labeled cholera toxin B subunit (CT-B), which binds to ganglioside GM1 present in lipid rafts (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>). For the phagocytosis experiments, opsonized latex beads were used as stimuli instead of yeast-derived zymosan, because the autofluorescence of the latter interfered with the signal from Alexa Fluor 647-labeled CT-B. The results were similar in both resting (Figures <xref ref-type="fig" rid="F6">6</xref>A,B) and phagocytizing cells (Figures <xref ref-type="fig" rid="F6">6</xref>C,D); treating either RAW 264.7 cells or RAW.108 cells with lysoPlsEtn, but not lysoPtdEtn, increased both the number and size of lipid rafts in the two types of cells similarly. The methodology used to quantify the lipid rafts is shown in (Figure <xref ref-type="fig" rid="F6">6</xref>E). Collectively, these results suggest that enriching the cells with ethanolamine plasmalogen selectively increases both the number and size of lipid rafts on the plasma membrane, and the overall phagocytic capacity of the cells.</p><fig id="F6" position="float"><label>Figure 6</label><caption><p>Effect of lysoPlsEtn on membrane rafts in RAW264.7 and plasmalogen-deficient RAW.108 cells. The cells were either untreated (brown bars) or treated with 10&#x02009;&#x000b5;M lysoPlsEtn (orange bars) or 10&#x02009;&#x000b5;M lysoPtdEtn (yellow bars) for 10&#x02009;min. Then the cells were incubated for 30&#x02009;min in the absence <bold>(A,B)</bold> or presence <bold>(C,D)</bold> of opsonized latex beads (10 particles per cell), stained with fluorescent cholera toxin (CT-B), and analyzed for lipid raft content by confocal microscopy (red color, middle columns). DAPI (1&#x02009;&#x000b5;g/ml) was used to mark the nuclei (blue; left columns). Nomarski images are also shown (right columns). The average of three independent experiments with 20 determinations each is shown (mean&#x02009;&#x000b1;&#x02009;SEM) (bottom panel). Original magnification, &#x000d7;63. *Significantly different (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) from untreated cells. <bold>(E)</bold> Methodology utilized to quantify lipid rafts: (a,e): native images marked with CT-B [(a) control RAW 264.7; (e) RAW 264.7&#x02009;+&#x02009;lysoPlsEtn]; (b,f) threshold and transform into an 8-bit binary images with MaxEntropy algorithm of ImageJ Threshold tools software; (c,d,g,h) determination and quantification of lipid raft microdomains being equal or greater than 0.1&#x02009;&#x000b5;m<sup>2</sup> [(d,h) lipid raft overlay on native images].</p></caption><graphic xlink:href="fimmu-09-01723-g006a"/><graphic xlink:href="fimmu-09-01723-g006b"/></fig><p>Due to their chemical structure, plasmalogens are known to profoundly affect membrane fluidity (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>). To define whether cellular plasmalogen content is a key regulator of membrane biophysical properties, we carried experiments to analyze the membrane fluidity of RAW 264.7 and RAW.108 cells by FRAP using confocal laser microscopy (<xref rid="B70" ref-type="bibr">70</xref>, <xref rid="B71" ref-type="bibr">71</xref>). Figure <xref ref-type="fig" rid="F7">7</xref> shows that the membrane mobile fraction of RAW264.7 cells remains basically unaltered after treating the cells with lysoPlsEtn, which was to be expected since, as indicated previously, treating these cells with exogenous lysoPlsEtn only slightly increases the amount of cellular ethanolamine plasmalogen of the cells (Figure <xref ref-type="fig" rid="F3">3</xref>). Addition of lysoPtdEtn also had no effect. Untreated plasmalogen-deficient RAW.108 cells showed a significantly greater baseline membrane mobile fraction than normal RAW 264.7 cells, indicating that the membrane of these cells is more fluid than that of normal RAW 264.7 cells. Interestingly, when the RAW.108 cells were exposed to lysoPlsEtn but not to lysoPtdEtn, the membrane mobile fraction decreased, reaching values similar to those of normal RAW 264.7 cells. These data demonstrate that increasing plasmalogen levels in RAW.108 cells reduces cell membrane fluidity down to levels found in cells exhibiting normal plasmalogen levels, thus providing a rationale to explain the reduced phagocytic capacity of RAW.108 cells compared to normal RAW 264.7 cells.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p>Analysis of membrane fluidity in RAW 264.7 and plasmalogen-deficient RAW.108 cells. The cells were either untreated (brown bars) or treated with 10&#x02009;&#x000b5;M lysoPlsEtn (orange bars) or 10&#x02009;&#x000b5;M lysoPtdEtn (yellow bars) for 10&#x02009;min, were stained with fluorescent cholera toxin (CT-B) for fluorescence recovery after photobleaching (FRAP) <italic>in vivo</italic> by confocal microscopy. <bold>(A)</bold> During FRAP image acquisition, a number of images were collected before, during and after photobleaching of a defined region of interest (white square). <bold>(B)</bold> Left panel, quantification of the mean fluorescence in the regions of interest; an absolute intensity trace showing a typical bleach of 90&#x02013;100% is illustrated. Right panel, normalized recovery after photobleaching, showing recovery of membrane fluorescence. <bold>(C)</bold> Comparison of the mobile fraction of membrane fluorescence after bleaching in RAW 264.7 and RAW.108 cells. Data in <bold>(C)</bold> are the average of three independent experiments of 40 determinations (mean&#x02009;&#x000b1;&#x02009;SEM). **Significantly different (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) with respect to untreated RAW.108 cells. *Significantly different (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) with respect to untreated RAW264.7 cells. Original magnification, &#x000d7;63.</p></caption><graphic xlink:href="fimmu-09-01723-g007"/></fig><p>In order to clarify further how ethanolamine plasmalogens are involved in phagocytosis, we investigated whether lysoplasmalogen treatment of RAW.108 cells results in plasma membrane enrichment with phagocytic receptors. To this purpose, we analyzed the surface expression of CD11b, CD16, CD32, and CD64 by confocal microscopy using fluorochrome-coupled antibodies. No significant change in the expression of either of these receptors at the membrane, within or without lipid rafts, could be detected after treating the cells with lysoPlsEtn and OpZ. Thus these results suggest that surface expression of phagocytic receptors is not dependent upon plasmalogen content at the membrane. Importantly, however, we observed that lysoPlsEtn treatment of the RAW.108 cells significantly increased the phosphorylation activation of the extracellular-regulated kinases p44 and p42 by OpZ (Figure <xref ref-type="fig" rid="F8">8</xref>). These data suggest that plasmalogens bolster up the intracellular signaling that originates from phagocytic receptors, which may be instrumental to support an optimal phagocytosis response. Of note, treating the cells with lysoPtdEtn did not increase the zymosan-stimulated phosphorylation of p44/p42, highlighting the specificity of the lysoPlsEtn effect.</p><fig id="F8" position="float"><label>Figure 8</label><caption><p>Effect of lysophospholipids on zymosan-induced signaling. RAW.108 cells were incubated with 10&#x02009;&#x000b5;M lysoPtdEtn, 10&#x02009;&#x000b5;M lysoPlsEtn or neither, as indicated, for 10&#x02009;min. Afterward, the cells were stimulated with opsonized zymosan (OpZ) for the indicated times, and the phosphorylation of extracellular-regulated kinases (ERK) p44 and p42 was studied by immunoblot. The panel below the blots shows the relative quantification of p44 and p42 phosphorylation with respect to total ERK.</p></caption><graphic xlink:href="fimmu-09-01723-g008"/></fig></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>In this work, we show that plasmalogen deficiency in macrophages is associated with reduced phagocytosis. Such a reduction is significantly reversed when the cells are exposed to lysoPlsEtn, a strategy that restores in part cellular plasmalogen levels, especially the fraction containing arachidonic acid. The increase in the phagocytic capacity of OpZ experienced by RAW.108 cells after cellular plasmalogen restoration is accompanied by an increase in the number and size of lipid raft microdomains. While plasmalogen restoration may occur into the lipid draft, the possibility also exists that it takes place at other locations of the membrane, and still play a key role in the phagocytosis process. On the other hand, our results also raise the intriguing possibility that direct contact could exist between membrane plasmalogen and the opsonized target, this favoring phagocytosis of opsonized targets without the critical involvement of a phagocytic receptor. In this regard, recent work by Nakayama et al. (<xref rid="B72" ref-type="bibr">72</xref>) has demonstrated phagocytosis of mycobacteria by neutrophils <italic>via</italic> direct binding of bacterial lipoarabinomannan to lactosylceramide moieties in membrane lipid rafts.</p><p>Previous reports demonstrated that ethanolamine plasmalogens tend to accumulate in lipid raft microdomains (<xref rid="B22" ref-type="bibr">22</xref>), and are essential to maintain the stability of this structure (<xref rid="B73" ref-type="bibr">73</xref>). The unique biological properties of this class of phospholipids has been related to the presence of the <italic>sn-2</italic> vinyl ether link, which may influence membrane packing and, hence, some key biophysical properties such as fluidity, fusion tendency, and thickness (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>). It is thus relevant that in our study, exposing the cells to lysoPtdEtn has no effect on macrophage phagocytosis of OpZ, pointing out to the specificity of the plasmalogen vinyl ether moiety. The vinyl ether linkage at the <italic>sn-1</italic> position of plasmalogens allows the proximal regions of the <italic>sn-1</italic> and <italic>sn-2</italic> chains to become parallel, diminishing the distances between the carbons of these chains (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>). This enhances condensation and ordering of phospholipids in the membrane, resulting in decreased membrane fluidity (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>). As a result of this, ethanolamine plasmalogens form more condensed and thicker membranes than diacyl ethanolamine phospholipids, because the vinyl ether bond increased the thickness and decreased area per lipid by higher ordering of the <italic>sn</italic>-1 alkenyl chain, increasing the membrane packing and density (<xref rid="B73" ref-type="bibr">73</xref>). In perfect agreement with these data our FRAP analyses by confocal microscopy clearly indicate that increased plasmalogen levels in the cells decreases the fluidity of plasma membranes, i.e., increases membrane packing, and makes it comparable to that found in cells exhibiting normal plasmalogen levels. Rigidization of the plasma membrane by increased plasmalogen content may allow the formation of lipid raft microdomains, improve recruitment, oligomerization, and interaction of receptors and signaling proteins involved in phagocytosis.</p><p>Also related with plasmalogen structure, it is noteworthy that most of the lipid formed from exogenous lysoPlsEtn in our system contained arachidonic acid. While arachidonate-containing plasmalogen is indeed the major species found in normal RAW 264.7 cells, and also in primary macrophages (<xref rid="B43" ref-type="bibr">43</xref>), the former cells also contain measurable amounts of ethanolamine plasmalogen carrying oleic acid, dihomo-&#x003b3;-linolenic, acid and several omega-3 fatty acids, all of which were formed only modestly in the lysoPlsEtn-treated cells. We speculate that the marked arachidonate preference for acylation of lysoPlsEtn in these cells is a direct consequence of the exceedingly high coenzyme A-independent transacylase activity (CoA-IT) that macrophage cell lines exhibit (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B60" ref-type="bibr">60</xref>, <xref rid="B74" ref-type="bibr">74</xref>&#x02013;<xref rid="B76" ref-type="bibr">76</xref>). This enzyme catalyzes the selective incorporation of arachidonate moieties into ether lipids in a process directed to preserve membrane homeostasis by ensuring the appropriate distribution of this fatty acid among the various phospholipid pools (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B77" ref-type="bibr">77</xref>). The rapid action of CoA-IT likely depletes the lysoPlsEtn that has been provided to the cells, thus leaving no lysolipid available for acylation with other fatty acids <italic>via</italic> slower CoA-dependent reactions. From a biological point of view, this disparity in the formation of newly synthesized plasmalogen by the RAW.108 cells may explain why the recovery of the phagocytosis response is still lower than that observed in normal RAW 264.7 cells. Nevertheless, the recovery of phagocytosis, albeit incomplete, parallels the increase in number and size of lipid rafts in the membranes of the cells, suggesting that both events are closely related. Although arachidonate, as a polyunsaturated fatty acid, tends to increase the fluidity of the membranes to which it incorporates (<xref rid="B78" ref-type="bibr">78</xref>), our results clearly suggest that the thickening effect of the <italic>sn-1</italic> vinyl ether predominates over the fluidizing effect of the polyunsaturate at the <italic>sn-2</italic> position, since the net effect is a loss of membrane fluidity. It is possible that the enrichment of arachidonate in newly formed plasmalogens provides a counteracting force for finer regulation of changes of the biophysical properties of the membrane.</p><p>Due to their tendency to form non-bilayer structures, ethanolamine plasmalogens have also been found to facilitate membrane fusion and fission processes. These phospholipids reduce the transition temperature from non-lamellar to inverted hexagonal phase, exhibiting a high propensity to form an inverse hexagonal phase, which is essential for membrane fusion. Plasmalogens also reduce surface tension, which facilitates membrane fusion as well (<xref rid="B79" ref-type="bibr">79</xref>). In this regard, studies with fibroblasts derived from ether lipid-deficient human patients have reported marked decreases in exocytosis and endocytosis processes (<xref rid="B80" ref-type="bibr">80</xref>, <xref rid="B81" ref-type="bibr">81</xref>). It has been found that, during phagocytosis, formation of the phagosome requires sealing of the phagosomal membrane <italic>via</italic> fusion processes that are in turn facilitated if the membrane is enriched with fusogenic lipids (<xref rid="B82" ref-type="bibr">82</xref>). Our results showing that restoring plasmalogen levels to RAW.108 cells increases phagocytosis are fully in accord with this view.</p><p>To conclude, our study provides novel data on the importance of plasmalogens in macrophage function and highlights the importance of ethanolamine plasmalogens in maintaining membrane fluidity and formation and organization of lipid rafts, and underscores their relevance for optimal cellular signaling that allows for an effective phagocytosis process. It is well established that the immune system deteriorates with age, which increases the risk of infections, autoimmunity, metabolic disorders, neurodegenerative and cardiovascular diseases, and cancer. Aging impacts on many macrophage processes such as phagocytosis, which may be related with the reduction of plasmalogen levels that is observed in these cells with aging (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B83" ref-type="bibr">83</xref>). Therefore, exogenous administration of plasmalogens could be considered as a valid strategy to both improve macrophage function and reduce the lipid composition imbalances seen with aging, so that the burden of age-related diseases can be alleviated. Future studies should explore this intriguing possibility.</p></sec><sec id="S5"><title>Ethics Statement</title><p>This study was approved by the Ethics and Bioethics Committee of the Spanish National Research Council (CSIC) prior to its commencement. No animals or samples of human origin were utilized for the experiments described in this report.</p></sec><sec id="S6"><title>Author Contributions</title><p>JR conducted experiments, interpreted the data, and wrote the manuscript. AA and JC conducted experiments and interpreted the data. MB designed the experiments and interpreted the data. JB designed the experiments, interpreted the data, and wrote the manuscript. All authors reviewed and approved the manuscript.</p></sec><sec id="S7"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We are indebted to Dr. Raphael A. Zoeller (Boston University) for providing us with plasmalogen-deficient RAW.108 cells. We thank Montse Duque for excellent technical assistance.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by Grants SAF2016-80883-R and SAF2015-73000-EXP from the Spanish Ministry of Economy, Industry and Competitiveness, and Grant CSI073U16 from the Education Department of the Regional Government of Castile and Leon. CIBERDEM is an initiative of Instituto de Salud Carlos III.</p></fn></fn-group><sec id="S9"><title>Abbreviations</title><p>lysoPlsEtn, lysoplasmenylethanolamine (1-<italic>O</italic>-1&#x02032;-octadecyl-2-lyso-<italic>sn</italic>-glycero-3-phospho-ethanolamine); lysoPtdEtn, lysophosphatidylethanolamine (1-oleoyl-2-lyso-<italic>sn</italic>-glycero-3-phosphoethanolamine); FRAP, fluorescence recovery after photobleaching.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wynn</surname><given-names>TA</given-names></name><name><surname>Chawla</surname><given-names>A</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group>
<article-title>Macrophage biology in development, homeostasis and disease</article-title>. <source>Nature</source> (<year>2013</year>) <volume>496</volume>:<fpage>445</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1038/nature12034</pub-id><pub-id pub-id-type="pmid">23619691</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>PJ</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name></person-group>. <article-title>Protective and pathogenic functions of macrophage subsets</article-title>. <source>Nat Rev Immunol</source> (<year>2011</year>) <volume>11</volume>:<fpage>723</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1038/nri3073</pub-id><?supplied-pmid 21997792?><pub-id pub-id-type="pmid">21997792</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S</given-names></name></person-group>. <article-title>Pattern recognition receptors: doubling up for the innate immune response</article-title>. <source>Cell</source> (<year>2002</year>) <volume>111</volume>:<fpage>927</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1016/S0092-8674(02)01201-1</pub-id><?supplied-pmid 12507420?><pub-id pub-id-type="pmid">12507420</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akira</surname><given-names>S</given-names></name></person-group>. <article-title>TLR signaling</article-title>. <source>Curr Top Microbiol Immunol</source> (<year>2006</year>) <volume>311</volume>:<fpage>1</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1007/3-540-32636-7_1</pub-id><?supplied-pmid 17048703?><pub-id pub-id-type="pmid">17048703</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Underhill</surname><given-names>DM</given-names></name><name><surname>Ozinsky</surname><given-names>A</given-names></name></person-group>. <article-title>Phagocytosis of microbes: complexity in action</article-title>. <source>Annu Rev Immunol</source> (<year>2002</year>) <volume>20</volume>:<fpage>825</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.20.103001.114744</pub-id><?supplied-pmid 11861619?><pub-id pub-id-type="pmid">11861619</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Underhill</surname><given-names>DM</given-names></name><name><surname>Goodridge</surname><given-names>HS</given-names></name></person-group>. <article-title>Information processing during phagocytosis</article-title>. <source>Nat Rev Immunol</source> (<year>2012</year>) <volume>12</volume>:<fpage>492</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="doi">10.1038/nri3244</pub-id><?supplied-pmid 22699831?><pub-id pub-id-type="pmid">22699831</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S</given-names></name></person-group>. <article-title>Phagocytosis: an immunobiologic process</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>44</volume>:<fpage>463</fpage>&#x02013;<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2016.02.026</pub-id><?supplied-pmid 26982354?><pub-id pub-id-type="pmid">26982354</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aderem</surname><given-names>A</given-names></name></person-group>. <article-title>Phagocytosis and the inflammatory response</article-title>. <source>J Infect Dis</source> (<year>2003</year>) <volume>187</volume>:<fpage>S340</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1086/374747</pub-id><?supplied-pmid 12792849?><pub-id pub-id-type="pmid">12792849</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bournazos</surname><given-names>S</given-names></name><name><surname>Hart</surname><given-names>SP</given-names></name><name><surname>Chamberlain</surname><given-names>LH</given-names></name><name><surname>Glennie</surname><given-names>MJ</given-names></name><name><surname>Dransfield</surname><given-names>I</given-names></name></person-group>. <article-title>Association of FcgammaRIIa (CD32a) with lipid rafts regulates ligand binding activity</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<fpage>8026</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0900107</pub-id><?supplied-pmid 19494328?><pub-id pub-id-type="pmid">19494328</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beekman</surname><given-names>JM</given-names></name><name><surname>van der Linden</surname><given-names>JA</given-names></name><name><surname>van de Winkel</surname><given-names>JG</given-names></name><name><surname>Leusen</surname><given-names>JH</given-names></name></person-group>. <article-title>FcgammaRI (CD64) resides constitutively in lipid rafts</article-title>. <source>Immunol Lett</source> (<year>2008</year>) <volume>116</volume>:<fpage>149</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1016/j.imlet.2007.12.003</pub-id><?supplied-pmid 18207250?><pub-id pub-id-type="pmid">18207250</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Huo</surname><given-names>J</given-names></name><name><surname>Gunawan</surname><given-names>M</given-names></name><name><surname>Su</surname><given-names>IH</given-names></name><name><surname>Lam</surname><given-names>KP</given-names></name></person-group>. <article-title>Activated dectin-1 localizes to lipid raft microdomains for signaling and activation of phagocytosis and cytokine production in dendritic cells</article-title>. <source>J Biol Chem</source> (<year>2009</year>) <volume>284</volume>:<fpage>22005</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M109.009076</pub-id><?supplied-pmid 19525229?><pub-id pub-id-type="pmid">19525229</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serezani</surname><given-names>CH</given-names></name><name><surname>Aronoff</surname><given-names>DM</given-names></name><name><surname>Sitrin</surname><given-names>RG</given-names></name><name><surname>Peters-Golden</surname><given-names>M</given-names></name></person-group>
<article-title>Fc&#x003b3;RI ligation leads to a complex with BLT1 in lipid rafts that enhances rat lung macrophage antimicrobial functions</article-title>. <source>Blood</source> (<year>2009</year>) <volume>114</volume>:<fpage>3316</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2009-01-199919</pub-id><pub-id pub-id-type="pmid">19657115</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>H</given-names></name><name><surname>Yoshizaki</surname><given-names>F</given-names></name><name><surname>Prinetti</surname><given-names>A</given-names></name><name><surname>Sonnino</surname><given-names>S</given-names></name><name><surname>Mauri</surname><given-names>L</given-names></name><name><surname>Takamori</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Lyn-coupled LacCer-enriched lipid rafts are required for CD11b/CD18-mediated neutrophil phagocytosis of nonopsonized microorganisms</article-title>. <source>J Leukoc Biol</source> (<year>2008</year>) <volume>83</volume>:<fpage>728</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0707478</pub-id><?supplied-pmid 18055569?><pub-id pub-id-type="pmid">18055569</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peyron</surname><given-names>P</given-names></name><name><surname>Bordier</surname><given-names>C</given-names></name><name><surname>N&#x02019;Diaye</surname><given-names>EN</given-names></name><name><surname>Maridonneau-Parini</surname><given-names>I</given-names></name></person-group>. <article-title>Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins</article-title>. <source>J Immunol</source> (<year>2000</year>) <volume>165</volume>:<fpage>5186</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.165.9.5186</pub-id><?supplied-pmid 11046051?><pub-id pub-id-type="pmid">11046051</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>DM</given-names></name><name><surname>Yang</surname><given-names>CS</given-names></name><name><surname>Lee</surname><given-names>JY</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Choi</surname><given-names>HH</given-names></name><name><surname>Lee</surname><given-names>HM</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> lipoprotein-induced association of TLR2 with protein kinase C zeta in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages</article-title>. <source>Cell Microbiol</source> (<year>2008</year>) <volume>10</volume>:<fpage>1893</fpage>&#x02013;<lpage>905</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2008.01179.x</pub-id><?supplied-pmid 18503635?><pub-id pub-id-type="pmid">18503635</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Triantafilou</surname><given-names>M</given-names></name><name><surname>Gamper</surname><given-names>FG</given-names></name><name><surname>Haston</surname><given-names>RM</given-names></name><name><surname>Mouratis</surname><given-names>MA</given-names></name><name><surname>Morath</surname><given-names>S</given-names></name><name><surname>Hartung</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting</article-title>. <source>J Biol Chem</source> (<year>2006</year>) <volume>281</volume>:<fpage>31002</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M602794200</pub-id><?supplied-pmid 16880211?><pub-id pub-id-type="pmid">16880211</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Gerl</surname><given-names>MJ</given-names></name></person-group>. <article-title>Revitalizing membrane rafts: new tools and insights</article-title>. <source>Nat Rev Mol Cell Biol</source> (<year>2010</year>) <volume>11</volume>:<fpage>688</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1038/nrm2977</pub-id><?supplied-pmid 20861879?><pub-id pub-id-type="pmid">20861879</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Ikonen</surname><given-names>E</given-names></name></person-group>. <article-title>Functional rafts in cell membranes</article-title>. <source>Nature</source> (<year>1997</year>) <volume>387</volume>:<fpage>569</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1038/42408</pub-id><?supplied-pmid 9177342?><pub-id pub-id-type="pmid">9177342</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diaz-Rohrer</surname><given-names>BB</given-names></name><name><surname>Levental</surname><given-names>KR</given-names></name><name><surname>Simons</surname><given-names>K</given-names></name><name><surname>Levental</surname><given-names>I</given-names></name></person-group>. <article-title>Membrane raft association is a determinant of plasma membrane localization</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2014</year>) <volume>111</volume>:<fpage>8500</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.1404582111</pub-id><?supplied-pmid 24912166?><pub-id pub-id-type="pmid">24912166</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname><given-names>P</given-names></name><name><surname>Yadav</surname><given-names>V</given-names></name><name><surname>Saini</surname><given-names>N</given-names></name></person-group>. <article-title>Lipid rafts in immune signalling: current progress and future perspective</article-title>. <source>Immunology</source> (<year>2016</year>) <volume>149</volume>:<fpage>13</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1111/imm.12617</pub-id><?supplied-pmid 27153983?><pub-id pub-id-type="pmid">27153983</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>FS</given-names></name><name><surname>Correa</surname><given-names>G</given-names></name><name><surname>Einicker-Lamas</surname><given-names>M</given-names></name><name><surname>Coutinho-Silva</surname><given-names>R</given-names></name></person-group>
<article-title>Host-cell lipid rafts: a safe door for micro-organisms</article-title>. <source>Biol Cell</source> (<year>2010</year>) <volume>102</volume>:<fpage>391</fpage>&#x02013;<lpage>407</lpage>.<pub-id pub-id-type="doi">10.1042/BC20090138</pub-id><pub-id pub-id-type="pmid">20377525</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pike</surname><given-names>LJ</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Chung</surname><given-names>KN</given-names></name><name><surname>Gross</surname><given-names>RW</given-names></name></person-group>. <article-title>Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis</article-title>. <source>Biochemistry</source> (<year>2002</year>) <volume>41</volume>:<fpage>2075</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="doi">10.1021/bi0156557</pub-id><?supplied-pmid 11827555?><pub-id pub-id-type="pmid">11827555</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamashita</surname><given-names>A</given-names></name><name><surname>Hayashi</surname><given-names>Y</given-names></name><name><surname>Nemoto-Sasaki</surname><given-names>Y</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Oka</surname><given-names>S</given-names></name><name><surname>Tanikawa</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and model organisms</article-title>. <source>Prog Lipid Res</source> (<year>2014</year>) <volume>53</volume>:<fpage>18</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.plipres.2013.10.001</pub-id><?supplied-pmid 24125941?><pub-id pub-id-type="pmid">24125941</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugiura</surname><given-names>T</given-names></name><name><surname>Nakajima</surname><given-names>M</given-names></name><name><surname>Sekiguchi</surname><given-names>N</given-names></name><name><surname>Nakagawa</surname><given-names>Y</given-names></name><name><surname>Waku</surname><given-names>K</given-names></name></person-group>
<article-title>Different fatty chain compositions of alkenylacyl, alkylacyl and diacyl phospholipids in rabbit alveolar macrophages: high amounts of arachidonic acid in ether phospholipids</article-title>. <source>Lipids</source> (<year>1983</year>) <volume>18</volume>:<fpage>125</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1007/BF02536106</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>ML</given-names></name><name><surname>Smith</surname><given-names>ZL</given-names></name><name><surname>Cress</surname><given-names>EA</given-names></name><name><surname>Snyder</surname><given-names>F</given-names></name></person-group>. <article-title>Molecular species of ethanolamine plasmalogens and transacylase activity in rat tissues are altered by fish oil diets</article-title>. <source>Biochim Biophys Acta</source> (<year>1994</year>) <volume>1214</volume>:<fpage>295</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="doi">10.1016/0005-2760(94)90076-0</pub-id><?supplied-pmid 7918612?><pub-id pub-id-type="pmid">7918612</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chilton</surname><given-names>FH</given-names></name><name><surname>Fonteh</surname><given-names>AN</given-names></name><name><surname>Surette</surname><given-names>ME</given-names></name><name><surname>Triggiani</surname><given-names>M</given-names></name><name><surname>Winkler</surname><given-names>JD</given-names></name></person-group>
<article-title>Control of arachidonate levels within inflammatory cells</article-title>. <source>Biochim Biophys Acta</source> (<year>1996</year>) <volume>1299</volume>:<fpage>1</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1016/0005-2760(95)00169-7</pub-id><pub-id pub-id-type="pmid">8555241</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Balgoma</surname><given-names>D</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Dynamics of arachidonic acid mobilization by inflammatory cells</article-title>. <source>Biochim Biophys Acta</source> (<year>2012</year>) <volume>1821</volume>:<fpage>249</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbalip.2011.11.006</pub-id><?supplied-pmid 22155285?><pub-id pub-id-type="pmid">22155285</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagan</surname><given-names>N</given-names></name><name><surname>Zoeller</surname><given-names>RA</given-names></name></person-group>
<article-title>Plasmalogens: biosynthesis and functions</article-title>. <source>Prog Lipid Res</source> (<year>2001</year>) <volume>40</volume>:<fpage>199</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="doi">10.1016/S0163-7827(01)00003-0</pub-id><pub-id pub-id-type="pmid">11275267</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koivuniemi</surname><given-names>A</given-names></name></person-group>. <article-title>The biophysical properties of plasmalogens originating from their unique molecular architecture</article-title>. <source>FEBS Lett</source> (<year>2017</year>) <volume>591</volume>:<fpage>2700</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1002/1873-3468.12754</pub-id><?supplied-pmid 28710769?><pub-id pub-id-type="pmid">28710769</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruip&#x000e9;rez</surname><given-names>V</given-names></name><name><surname>Casas</surname><given-names>J</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Group V phospholipase A<sub>2</sub>-derived lysophosphatidylcholine mediates cyclooxygenase-2 induction in lipopolysaccharide-stimulated macrophages</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<fpage>631</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.1.631</pub-id><?supplied-pmid 17579085?><pub-id pub-id-type="pmid">17579085</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pindado</surname><given-names>J</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name></person-group>. <article-title>TLR3-dependent induction of nitric oxide synthase in RAW 264.7 macrophage-like cells via a cytosolic phospholipase A<sub>2</sub>/cyclooxygenase-2 pathway</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>:<fpage>4821</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.179.7.4821</pub-id><?supplied-pmid 17878381?><pub-id pub-id-type="pmid">17878381</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruip&#x000e9;rez</surname><given-names>V</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Coordinate regulation of TLR-mediated arachidonic acid mobilization in macrophages by group IVA and group V phospholipase A<sub>2</sub>s</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<fpage>3877</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0804003</pub-id><?supplied-pmid 19265167?><pub-id pub-id-type="pmid">19265167</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Chac&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Ruip&#x000e9;rez</surname><given-names>V</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Signaling role for lysophosphatidylcholine acyltransferase 3 in receptor-regulated arachidonic acid reacylation reactions in human monocytes</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<fpage>1071</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0902257</pub-id><?supplied-pmid 20018618?><pub-id pub-id-type="pmid">20018618</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balgoma</surname><given-names>D</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>P&#x000e9;rez-Chac&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Montero</surname><given-names>O</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Markers of monocyte activation revealed by lipidomic profiling of arachidonic acid-containing phospholipids</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<fpage>3857</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0902883</pub-id><?supplied-pmid 20181887?><pub-id pub-id-type="pmid">20181887</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdearcos</surname><given-names>M</given-names></name><name><surname>Esquinas</surname><given-names>E</given-names></name><name><surname>Meana</surname><given-names>C</given-names></name><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Guijas</surname><given-names>C</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Subcellular localization and role of lipin-1 in human macrophages</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>6004</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1003279</pub-id><?supplied-pmid 21478406?><pub-id pub-id-type="pmid">21478406</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>P&#x000e9;rez-Chac&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Meana</surname><given-names>C</given-names></name><name><surname>Balgoma</surname><given-names>D</given-names></name><name><surname>Pol</surname><given-names>A</given-names></name><name><surname>Del Pozo</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Altered arachidonate distribution in macrophages from caveolin-1 null mice leading to reduced eicosanoid synthesis</article-title>. <source>J Biol Chem</source> (<year>2011</year>) <volume>286</volume>:<fpage>35299</fpage>&#x02013;<lpage>307</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M111.277137</pub-id><?supplied-pmid 21852231?><pub-id pub-id-type="pmid">21852231</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guijas</surname><given-names>C</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Rubio</surname><given-names>JM</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Phospholipid sources for adrenic acid mobilization in RAW 264.7 macrophages: comparison with arachidonic acid</article-title>. <source>Biochim Biophys Acta</source> (<year>2012</year>) <volume>1821</volume>:<fpage>1386</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbalip.2012.07.010</pub-id><?supplied-pmid 22824377?><pub-id pub-id-type="pmid">22824377</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Meana</surname><given-names>C</given-names></name><name><surname>Rubio</surname><given-names>JM</given-names></name><name><surname>Guijas</surname><given-names>C</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>A phosphatidylinositol species acutely generated by activated macrophages regulates innate immune responses</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<fpage>5169</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1203494</pub-id><?supplied-pmid 23567931?><pub-id pub-id-type="pmid">23567931</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Guijas</surname><given-names>C</given-names></name><name><surname>Magrioti</surname><given-names>V</given-names></name><name><surname>Kokotos</surname><given-names>G</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Cytosolic group IVA and calcium-independent group VIA phospholipase A<sub>2</sub>s act on distinct phospholipid pools in zymosan-stimulated mouse peritoneal macrophages</article-title>. <source>J Immunol</source> (<year>2014</year>) <volume>192</volume>:<fpage>752</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1302267</pub-id><?supplied-pmid 24337743?><pub-id pub-id-type="pmid">24337743</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubio</surname><given-names>JM</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>JP</given-names></name><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Guijas</surname><given-names>C</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>
<article-title>Group V secreted phospholipase A<sub>2</sub> is up-regulated by interleukin-4 in human macrophages and mediates phagocytosis via hydrolysis of ethanolamine phospholipids</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>:<fpage>3327</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1401026</pub-id><pub-id pub-id-type="pmid">25725101</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Lebrero</surname><given-names>P</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Essential role for ethanolamine plasmalogen hydrolysis in bacterial lipopolysaccharide priming of macrophages for enhanced arachidonic acid release</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<fpage>1251</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2017.01251</pub-id><?supplied-pmid 29033952?><pub-id pub-id-type="pmid">29033952</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoeller</surname><given-names>RA</given-names></name><name><surname>Rangaswamy</surname><given-names>S</given-names></name><name><surname>Herscovitz</surname><given-names>H</given-names></name><name><surname>Rizzo</surname><given-names>WB</given-names></name><name><surname>Hajra</surname><given-names>AK</given-names></name><name><surname>Das</surname><given-names>AK</given-names></name><etal/></person-group>
<article-title>Mutants in a macrophage-like cell line are defective in plasmalogen biosynthesis, but contain functional peroxisomes</article-title>. <source>J Biol Chem</source> (<year>1992</year>) <volume>267</volume>:<fpage>8299</fpage>&#x02013;<lpage>306</lpage>.<?supplied-pmid 1569085?><pub-id pub-id-type="pmid">1569085</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gaposchkin</surname><given-names>DP</given-names></name><name><surname>Farber</surname><given-names>HW</given-names></name><name><surname>Zoeller</surname><given-names>RA</given-names></name></person-group>. <article-title>On the importance of plasmalogen status in stimulated arachidonic acid release in the macrophage cell line RAW 264.7</article-title>. <source>Biochim Biophys Acta</source> (<year>2008</year>) <volume>1781</volume>:<fpage>213</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbalip.2008.01.007</pub-id><?supplied-pmid 18328831?><pub-id pub-id-type="pmid">18328831</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>B</given-names></name><name><surname>Diez</surname><given-names>E</given-names></name></person-group>. <article-title>Regulation of arachidonic acid release in mouse peritoneal macrophages. The role of extracellular calcium and protein kinase C</article-title>. <source>J Immunol</source> (<year>1990</year>) <volume>144</volume>:<fpage>4298</fpage>&#x02013;<lpage>304</lpage>.<?supplied-pmid 2111343?><pub-id pub-id-type="pmid">2111343</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>B</given-names></name><name><surname>Sol&#x000ed;s-Herruzo</surname><given-names>JA</given-names></name><name><surname>Diez</surname><given-names>E</given-names></name></person-group>. <article-title>Pathways for arachidonic acid mobilization in zymosan-stimulated mouse peritoneal macrophages</article-title>. <source>Biochim Biophys Acta</source> (<year>1992</year>) <volume>1136</volume>:<fpage>75</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/0167-4889(92)90087-R</pub-id><?supplied-pmid 1643116?><pub-id pub-id-type="pmid">1643116</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>S&#x000e1;ez</surname><given-names>Y</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Calcium-independent phospholipase A<sub>2</sub> is required for lysozyme secretion in U937 promonocytes</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>170</volume>:<fpage>5276</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.170.10.5276</pub-id><?supplied-pmid 12734377?><pub-id pub-id-type="pmid">12734377</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>R</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Amplification mechanisms of inflammation: paracrine stimulation of arachidonic acid mobilization by secreted phospholipase A<sub>2</sub> is regulated by cytosolic phospholipase A<sub>2</sub>-derived hydroperoxyeicosatetraenoic acid</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>171</volume>:<fpage>989</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.171.2.989</pub-id><?supplied-pmid 12847271?><pub-id pub-id-type="pmid">12847271</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname><given-names>J</given-names></name><name><surname>Gij&#x000f3;n</surname><given-names>MA</given-names></name><name><surname>Vigo</surname><given-names>AG</given-names></name><name><surname>Crespo</surname><given-names>MS</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name></person-group>. <article-title>Phosphatidylinositol 4,5-bisphosphate anchors cytosolic group IVA phospholipase A<sub>2</sub> to perinuclear membranes and decreases its calcium requirement for translocation in live cells</article-title>. <source>Mol Biol Cell</source> (<year>2006</year>) <volume>17</volume>:<fpage>155</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1091/mbc.e05-06-0545</pub-id><?supplied-pmid 16221889?><pub-id pub-id-type="pmid">16221889</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>R</given-names></name><name><surname>Matabosch</surname><given-names>X</given-names></name><name><surname>Llebaria</surname><given-names>A</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Blockade of arachidonic acid incorporation into phospholipids induces apoptosis in U937 promonocytic cells</article-title>. <source>J Lipid Res</source> (<year>2006</year>) <volume>47</volume>:<fpage>484</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1194/jlr.M500397-JLR200</pub-id><?supplied-pmid 16326977?><pub-id pub-id-type="pmid">16326977</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Dennis</surname><given-names>EA</given-names></name></person-group>. <article-title>Identification of a third pathway for arachidonic acid mobilization and prostaglandin production in activated P388D<sub>1</sub> macrophage-like cells</article-title>. <source>J Biol Chem</source> (<year>2000</year>) <volume>275</volume>:<fpage>22544</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M910163199</pub-id><?supplied-pmid 10811815?><pub-id pub-id-type="pmid">10811815</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradford</surname><given-names>MM</given-names></name></person-group>
<article-title>A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding</article-title>. <source>Anal Biochem</source> (<year>1976</year>) <volume>72</volume>:<fpage>248</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1016/0003-2697(76)90527-3</pub-id><pub-id pub-id-type="pmid">942051</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balestrieri</surname><given-names>B</given-names></name><name><surname>Hsu</surname><given-names>VW</given-names></name><name><surname>Gilbert</surname><given-names>H</given-names></name><name><surname>Leslie</surname><given-names>CC</given-names></name><name><surname>Han</surname><given-names>WK</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name><etal/></person-group>
<article-title>Group V secretory phospholipase A<sub>2</sub> translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis</article-title>. <source>J Biol Chem</source> (<year>2006</year>) <volume>281</volume>:<fpage>6691</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M508314200</pub-id><?supplied-pmid 16407308?><pub-id pub-id-type="pmid">16407308</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>R</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Involvement of group VIA calcium-independent phospholipase A<sub>2</sub> in macrophage engulfment of hydrogen peroxide-treated U937 cells</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<fpage>2555</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.4.2555</pub-id><?supplied-pmid 16456017?><pub-id pub-id-type="pmid">16456017</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez</surname><given-names>R</given-names></name><name><surname>Melero</surname><given-names>R</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Role of group VIA calcium-independent phospholipase A<sub>2</sub> in arachidonic acid release, phospholipid fatty acid incorporation, and apoptosis in U937 cells responding to hydrogen peroxide</article-title>. <source>J Biol Chem</source> (<year>2004</year>) <volume>279</volume>:<fpage>40385</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M402562200</pub-id><?supplied-pmid 15252038?><pub-id pub-id-type="pmid">15252038</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaikh</surname><given-names>SR</given-names></name><name><surname>Rockett</surname><given-names>BD</given-names></name><name><surname>Salameh</surname><given-names>M</given-names></name><name><surname>Carraway</surname><given-names>K</given-names></name></person-group>. <article-title>Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells</article-title>. <source>J Nutr</source> (<year>2009</year>) <volume>139</volume>:<fpage>1632</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.3945/jn.109.108720</pub-id><?supplied-pmid 19640970?><pub-id pub-id-type="pmid">19640970</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giakoumakis</surname><given-names>NN</given-names></name><name><surname>Rapsomaniki</surname><given-names>MA</given-names></name><name><surname>Lygerou</surname><given-names>Z</given-names></name></person-group>
<article-title>Analysis of protein kinetics using fluorescence recovery after photobleaching (FRAP)</article-title>. <source>Methods Mol Biol</source> (<year>2017</year>) <volume>1563</volume>:<fpage>243</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1007/978-1-4939-6810-7_16</pub-id><pub-id pub-id-type="pmid">28324613</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnell</surname><given-names>M</given-names></name><name><surname>Macmillan</surname><given-names>A</given-names></name><name><surname>Whan</surname><given-names>R</given-names></name></person-group>
<article-title>Fluorescence recovery after photobleaching (FRAP): acquisition, analysis, and applications</article-title>. <source>Methods Mol Biol</source> (<year>2015</year>) <volume>1232</volume>:<fpage>255</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1007/978-1-4939-1752-5_18</pub-id><pub-id pub-id-type="pmid">25331140</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>CY</given-names></name><name><surname>Petralia</surname><given-names>RS</given-names></name><name><surname>Wang</surname><given-names>YX</given-names></name><name><surname>Kachar</surname><given-names>B</given-names></name></person-group>. <article-title>Fluorescence recovery after photobleaching (FRAP) of fluorescence tagged proteins in dendritic spines of cultured hippocampal neurons</article-title>. <source>J Vis Exp</source> (<year>2011</year>) <volume>50</volume>:<fpage>2568</fpage>.<pub-id pub-id-type="doi">10.3791/2568</pub-id><?supplied-pmid 21525845?><pub-id pub-id-type="pmid">21525845</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdearcos</surname><given-names>M</given-names></name><name><surname>Esquinas</surname><given-names>E</given-names></name><name><surname>Meana</surname><given-names>C</given-names></name><name><surname>Pe&#x000f1;a</surname><given-names>L</given-names></name><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages</article-title>. <source>J Biol Chem</source> (<year>2012</year>) <volume>287</volume>:<fpage>10894</fpage>&#x02013;<lpage>904</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M112.342915</pub-id><?supplied-pmid 22334674?><pub-id pub-id-type="pmid">22334674</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>P&#x000e9;rez-Chac&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Balgoma</surname><given-names>D</given-names></name><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Ruip&#x000e9;rez</surname><given-names>V</given-names></name><name><surname>Guijas</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Influence of cellular arachidonic acid levels on phospholipid remodeling and CoA-independent transacylase activity in human monocytes and U937 cells</article-title>. <source>Biochim Biophys Acta</source> (<year>2011</year>) <volume>1811</volume>:<fpage>97</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbalip.2010.11.009</pub-id><?supplied-pmid 21145415?><pub-id pub-id-type="pmid">21145415</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guijas</surname><given-names>C</given-names></name><name><surname>P&#x000e9;rez-Chac&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Rubio</surname><given-names>JM</given-names></name><name><surname>Gil-de-G&#x000f3;mez</surname><given-names>L</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Simultaneous activation of p38 and JNK by arachidonic acid stimulates the cytosolic phospholipase A<sub>2</sub>-dependent synthesis of lipid droplets in human monocytes</article-title>. <source>J Lipid Res</source> (<year>2012</year>) <volume>53</volume>:<fpage>2343</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="doi">10.1194/jlr.M028423</pub-id><?supplied-pmid 22949356?><pub-id pub-id-type="pmid">22949356</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guijas</surname><given-names>C</given-names></name><name><surname>Meana</surname><given-names>C</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Foamy monocytes are enriched in cis-7-hexadecenoic fatty acid (16:1<italic>n-9</italic>), a possible biomarker for early detection of cardiovascular disease</article-title>. <source>Cell Chem Biol</source> (<year>2016</year>) <volume>23</volume>:<fpage>689</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1016/j.chembiol.2016.04.012</pub-id><?supplied-pmid 27265749?><pub-id pub-id-type="pmid">27265749</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Meana</surname><given-names>C</given-names></name><name><surname>Guijas</surname><given-names>C</given-names></name><name><surname>Pereira</surname><given-names>L</given-names></name><name><surname>Lebrero</surname><given-names>R</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><etal/></person-group>
<article-title>Occurrence and biological activity of palmitoleic acid isomers in phagocytic cells</article-title>. <source>J Lipid Res</source> (<year>2018</year>) <volume>59</volume>:<fpage>237</fpage>&#x02013;<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1194/jlr.M079145</pub-id><?supplied-pmid 29167413?><pub-id pub-id-type="pmid">29167413</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Dillon</surname><given-names>DA</given-names></name><name><surname>Carman</surname><given-names>GM</given-names></name><name><surname>Dennis</surname><given-names>EA</given-names></name></person-group>. <article-title>Proinflammatory macrophage-activating properties of the novel phospholipid diacylglycerol pyrophosphate</article-title>. <source>J Biol Chem</source> (<year>1999</year>) <volume>274</volume>:<fpage>522</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.274.1.522</pub-id><?supplied-pmid 9867874?><pub-id pub-id-type="pmid">9867874</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>PC</given-names></name><name><surname>Reichart</surname><given-names>D</given-names></name><name><surname>Dumlao</surname><given-names>DS</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Dennis</surname><given-names>EA</given-names></name></person-group>. <article-title>Specificity of eicosanoid production depends on the TLR-4-stimulated macrophage phenotype</article-title>. <source>J Leukoc Biol</source> (<year>2011</year>) <volume>90</volume>:<fpage>563</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0311153</pub-id><?supplied-pmid 21653236?><pub-id pub-id-type="pmid">21653236</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Insel</surname><given-names>PA</given-names></name><name><surname>Dennis</surname><given-names>EA</given-names></name></person-group>. <article-title>Differential regulation of phospholipase D and phospholipase A<sub>2</sub> by protein kinase C in P388D<sub>1</sub> macrophages</article-title>. <source>Biochem J</source> (<year>1997</year>) <volume>321</volume>:<fpage>805</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1042/bj3210805</pub-id><?supplied-pmid 9032469?><pub-id pub-id-type="pmid">9032469</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teruel</surname><given-names>JA</given-names></name><name><surname>Soler</surname><given-names>F</given-names></name><name><surname>G&#x000f3;mez-Fern&#x000e1;ndez</surname><given-names>JC</given-names></name></person-group>. <article-title>On the effect of lysophosphatidylcholine, platelet activating factor and other surfactants on calcium permeability in sarcoplasmic reticulum vesicles</article-title>. <source>Chem Phys Lipids</source> (<year>1991</year>) <volume>59</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/0009-3084(91)90057-I</pub-id><?supplied-pmid 1790577?><pub-id pub-id-type="pmid">1790577</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermetter</surname><given-names>A</given-names></name><name><surname>Rainer</surname><given-names>B</given-names></name><name><surname>Ivessa</surname><given-names>E</given-names></name><name><surname>Kalb</surname><given-names>E</given-names></name><name><surname>Loidl</surname><given-names>J</given-names></name><name><surname>Roscher</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Influence of plasmalogen deficiency on membrane fluidity of human skin fibroblasts: a fluorescence anisotropy study</article-title>. <source>Biochim Biophys Acta</source> (<year>1989</year>) <volume>978</volume>:<fpage>151</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/0005-2736(89)90510-5</pub-id><?supplied-pmid 2914126?><pub-id pub-id-type="pmid">2914126</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paltauf</surname><given-names>F</given-names></name></person-group>. <article-title>Ether lipids in biomembranes</article-title>. <source>Chem Phys Lipids</source> (<year>1994</year>) <volume>74</volume>:<fpage>101</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1016/0009-3084(94)90054-X</pub-id><?supplied-pmid 7859340?><pub-id pub-id-type="pmid">7859340</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kenworthy</surname><given-names>AK</given-names></name><name><surname>Nichols</surname><given-names>BJ</given-names></name><name><surname>Remmert</surname><given-names>CL</given-names></name><name><surname>Hendrix</surname><given-names>GM</given-names></name><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Zimmerberg</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Dynamics of putative raft-associated proteins at the cell surface</article-title>. <source>J Cell Biol</source> (<year>2004</year>) <volume>165</volume>:<fpage>735</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1083/jcb.200312170</pub-id><?supplied-pmid 15173190?><pub-id pub-id-type="pmid">15173190</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>JC</given-names></name><name><surname>Cheney</surname><given-names>PP</given-names></name><name><surname>Campbell</surname><given-names>T</given-names></name><name><surname>Knowles</surname><given-names>MK</given-names></name></person-group>. <article-title>Membrane curvature based lipid sorting using a nanoparticle patterned substrate</article-title>. <source>Soft Matter</source> (<year>2014</year>) <volume>10</volume>:<fpage>2016</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1039/c3sm52522h</pub-id><?supplied-pmid 24652483?><pub-id pub-id-type="pmid">24652483</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>H</given-names></name><name><surname>Kurihara</surname><given-names>H</given-names></name><name><surname>Morita</surname><given-names>YS</given-names></name><name><surname>Kinoshita</surname><given-names>T</given-names></name><name><surname>Mauri</surname><given-names>L</given-names></name><name><surname>Prinetti</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Lipoarabinomannan binding to lactosylceramide in lipid rafts is essential for the phagocytosis of mycobacteria by human neutrophils</article-title>. <source>Sci Signal</source> (<year>2016</year>) <volume>9</volume>:<fpage>ra101</fpage>.<pub-id pub-id-type="doi">10.1126/scisignal.aaf1585</pub-id><?supplied-pmid 27729551?><pub-id pub-id-type="pmid">27729551</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rog</surname><given-names>T</given-names></name><name><surname>Koivuniemi</surname><given-names>A</given-names></name></person-group>. <article-title>The biophysical properties of ethanolamine plasmalogens revealed by atomistic molecular dynamics simulations</article-title>. <source>Biochim Biophys Acta</source> (<year>2016</year>) <volume>1858</volume>:<fpage>97</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbamem.2015.10.023</pub-id><?supplied-pmid 26522077?><pub-id pub-id-type="pmid">26522077</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Barbour</surname><given-names>SE</given-names></name><name><surname>Bianco</surname><given-names>ID</given-names></name><name><surname>Dennis</surname><given-names>EA</given-names></name></person-group>
<article-title>Arachidonic acid mobilization in P388D<sub>1</sub> macrophages is controlled by two distinct Ca<sup>2+</sup>-dependent phospholipase A<sub>2</sub> enzymes</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1994</year>) <volume>91</volume>:<fpage>11060</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.91.23.11060</pub-id><pub-id pub-id-type="pmid">7972009</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Dennis</surname><given-names>EA</given-names></name></person-group>. <article-title>Distinct roles in signal transduction for each of the phospholipase A<sub>2</sub> enzymes present in P388D<sub>1</sub> macrophages</article-title>. <source>J Biol Chem</source> (<year>1996</year>) <volume>271</volume>:<fpage>6758</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.271.12.6758</pub-id><?supplied-pmid 8636097?><pub-id pub-id-type="pmid">8636097</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Yedgar</surname><given-names>S</given-names></name><name><surname>Dennis</surname><given-names>EA</given-names></name></person-group>
<article-title>Group V phospholipase A<sub>2</sub>-mediated oleic acid mobilization in lipopolysaccharide-stimulated P388D<sub>1</sub> macrophages</article-title>. <source>J Biol Chem</source> (<year>2000</year>) <volume>275</volume>:<fpage>4783</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.275.7.4783</pub-id><pub-id pub-id-type="pmid">10671511</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Chac&#x000f3;n</surname><given-names>G</given-names></name><name><surname>Astudillo</surname><given-names>AM</given-names></name><name><surname>Balgoma</surname><given-names>D</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name><name><surname>Balsinde</surname><given-names>J</given-names></name></person-group>. <article-title>Control of free arachidonic acid levels by phospholipases A<sub>2</sub> and lysophospholipid acyltransferases</article-title>. <source>Biochim Biophys Acta</source> (<year>2009</year>) <volume>1791</volume>:<fpage>1103</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="doi">10.1016/j.bbalip.2009.08.007</pub-id><?supplied-pmid 19715771?><pub-id pub-id-type="pmid">19715771</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holthuis</surname><given-names>JC</given-names></name><name><surname>Menon</surname><given-names>AK</given-names></name></person-group>. <article-title>Lipid landscapes and pipelines in membrane homeostasis</article-title>. <source>Nature</source> (<year>2014</year>) <volume>510</volume>:<fpage>48</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1038/nature13474</pub-id><?supplied-pmid 24899304?><pub-id pub-id-type="pmid">24899304</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marrink</surname><given-names>SJ</given-names></name><name><surname>Mark</surname><given-names>AE</given-names></name></person-group>. <article-title>Molecular view of hexagonal phase formation in phospholipid membranes</article-title>. <source>Biophys J</source> (<year>2004</year>) <volume>87</volume>:<fpage>3894</fpage>&#x02013;<lpage>900</lpage>.<pub-id pub-id-type="doi">10.1529/biophysj.104.048710</pub-id><?supplied-pmid 15377528?><pub-id pub-id-type="pmid">15377528</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thai</surname><given-names>TP</given-names></name><name><surname>Rodemer</surname><given-names>C</given-names></name><name><surname>Jauch</surname><given-names>A</given-names></name><name><surname>Hunziker</surname><given-names>A</given-names></name><name><surname>Moser</surname><given-names>A</given-names></name><name><surname>Gorgas</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Impaired membrane traffic in defective ether lipid biosynthesis</article-title>. <source>Hum Mol Genet</source> (<year>2001</year>) <volume>10</volume>:<fpage>127</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="doi">10.1093/hmg/10.2.127</pub-id><?supplied-pmid 11152660?><pub-id pub-id-type="pmid">11152660</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perichon</surname><given-names>R</given-names></name><name><surname>Moser</surname><given-names>AB</given-names></name><name><surname>Wallace</surname><given-names>WC</given-names></name><name><surname>Cunningham</surname><given-names>SC</given-names></name><name><surname>Roth</surname><given-names>GS</given-names></name><name><surname>Moser</surname><given-names>HW</given-names></name></person-group>. <article-title>Peroxisomal disease cell lines with cellular plasmalogen deficiency have impaired muscarinic cholinergic signal transduction activity and amyloid precursor protein secretion</article-title>. <source>Biochem Biophys Res Commun</source> (<year>1998</year>) <volume>248</volume>:<fpage>57</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="doi">10.1006/bbrc.1998.8909</pub-id><?supplied-pmid 9675085?><pub-id pub-id-type="pmid">9675085</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>R</given-names></name><name><surname>Grinstein</surname><given-names>S</given-names></name><name><surname>Canton</surname><given-names>J</given-names></name></person-group>. <article-title>The life cycle of phagosomes: formation, maturation, and resolution</article-title>. <source>Immunol Rev</source> (<year>2016</year>) <volume>273</volume>:<fpage>156</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12439</pub-id><?supplied-pmid 27558334?><pub-id pub-id-type="pmid">27558334</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maeba</surname><given-names>R</given-names></name><name><surname>Maeda</surname><given-names>T</given-names></name><name><surname>Kinoshita</surname><given-names>M</given-names></name><name><surname>Takao</surname><given-names>K</given-names></name><name><surname>Takenaka</surname><given-names>H</given-names></name><name><surname>Kusano</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Plasmalogens in human serum positively correlate with high-density lipoprotein and decrease with aging</article-title>. <source>J Atheroscler Thromb</source> (<year>2007</year>) <volume>14</volume>:<fpage>12</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.5551/jat.14.12</pub-id><pub-id pub-id-type="pmid">17332687</pub-id></mixed-citation></ref></ref-list></back></article>